• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Therapeutic targeting of oncogenic KRAS in pancreatic cancer by engineered exosomes.通过工程化外泌体对胰腺癌中致癌性KRAS进行治疗靶向
Transl Cancer Res. 2017 Dec;6(Suppl 9):S1406-S1408. doi: 10.21037/tcr.2017.10.32.
2
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer.外泌体有助于在胰腺癌中对致癌性KRAS进行治疗靶向。
Nature. 2017 Jun 22;546(7659):498-503. doi: 10.1038/nature22341. Epub 2017 Jun 7.
3
Oncogenic and Non-Malignant Pancreatic Exosome Cargo Reveal Distinct Expression of Oncogenic and Prognostic Factors Involved in Tumor Invasion and Metastasis.致癌和非恶性胰腺外体货物揭示了涉及肿瘤侵袭和转移的致癌和预后因素的不同表达。
Proteomics. 2019 Apr;19(8):e1800158. doi: 10.1002/pmic.201800158. Epub 2019 Apr 9.
4
Targeting integrin-linked kinase to suppress oncogenic KRAS signaling in pancreatic cancer.靶向整合素连接激酶以抑制胰腺癌中的致癌KRAS信号传导。
Small GTPases. 2018 Nov 2;9(6):452-456. doi: 10.1080/21541248.2016.1251383. Epub 2016 Dec 9.
5
Regulation of oncogenic KRAS signaling via a novel KRAS-integrin-linked kinase-hnRNPA1 regulatory loop in human pancreatic cancer cells.通过人胰腺癌细胞中新型KRAS-整合素连接激酶-hnRNPA1调控环对致癌性KRAS信号的调控
Oncogene. 2016 Jul 28;35(30):3897-908. doi: 10.1038/onc.2015.458. Epub 2015 Nov 30.
6
Generation and testing of clinical-grade exosomes for pancreatic cancer.生成和测试胰腺癌的临床级别的外泌体。
JCI Insight. 2018 Apr 19;3(8). doi: 10.1172/jci.insight.99263.
7
Pancreatic cancer: Exosomes for targeting KRAS in the treatment of pancreatic cancer.胰腺癌：用于治疗胰腺癌中靶向KRAS的外泌体
Nat Rev Gastroenterol Hepatol. 2017 Nov;14(11):636-638. doi: 10.1038/nrgastro.2017.113. Epub 2017 Sep 6.
8
A CRISPR-Cas13a system for efficient and specific therapeutic targeting of mutant KRAS for pancreatic cancer treatment.CRISPR-Cas13a 系统用于高效、特异性靶向突变 KRAS 的胰腺癌治疗。
Cancer Lett. 2018 Sep 1;431:171-181. doi: 10.1016/j.canlet.2018.05.042. Epub 2018 Jun 2.
9
SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer.SOX9 的活性受致癌性 Kras 的诱导，从而影响胰腺癌中 MDC1 和 MCMs 的表达。
Oncogene. 2018 Feb 15;37(7):912-923. doi: 10.1038/onc.2017.393. Epub 2017 Oct 23.
10
Sequential Targeting TGF-β Signaling and KRAS Mutation Increases Therapeutic Efficacy in Pancreatic Cancer.序贯靶向 TGF-β 信号和 KRAS 突变可提高胰腺癌的治疗效果。
Small. 2019 Jun;15(24):e1900631. doi: 10.1002/smll.201900631. Epub 2019 Apr 29.

引用本文的文献

1
Exosomes in Hepatocellular Carcinoma: A Comprehensive Review of Current Research and Future Directions.肝细胞癌中的外泌体：当前研究与未来方向的全面综述
J Cell Mol Med. 2025 Jul;29(14):e70723. doi: 10.1111/jcmm.70723.
2
Recent advances in engineered exosome-based therapies for ocular vascular disease.基于工程外泌体的眼部血管疾病治疗的最新进展
J Nanobiotechnology. 2025 Jul 19;23(1):526. doi: 10.1186/s12951-025-03589-3.
3
Effect of Extracellular Vesicles Derived From Tumor Cells on Immune Evasion.肿瘤细胞衍生的细胞外囊泡对免疫逃逸的影响。
Adv Sci (Weinh). 2025 Mar;12(12):e2417357. doi: 10.1002/advs.202417357. Epub 2025 Feb 3.
4
Extracellular vesicles: from intracellular trafficking molecules to fully fortified delivery vehicles for cancer therapeutics.细胞外囊泡：从细胞内运输分子到用于癌症治疗的全面强化递送载体。
Nanoscale Adv. 2025 Jan 15;7(4):934-962. doi: 10.1039/d4na00393d. eCollection 2025 Feb 11.
5
Investigation of the efficacy of siRNA-mediated KRAS gene silencing in pancreatic cancer therapy.siRNA 介导的 KRAS 基因沉默在胰腺癌治疗中的疗效研究。
PeerJ. 2024 Nov 12;12:e18214. doi: 10.7717/peerj.18214. eCollection 2024.
6
Emerging Roles of Small Extracellular Vesicles in Gastrointestinal Cancer Research and Therapy.小细胞外囊泡在胃肠道癌研究与治疗中的新作用
Cancers (Basel). 2024 Jan 29;16(3):567. doi: 10.3390/cancers16030567.
7
Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management.细胞外囊泡作为癌症治疗中的潜在治疗信使
Biology (Basel). 2023 Apr 27;12(5):665. doi: 10.3390/biology12050665.
8
Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment.基于小干扰RNA的纳米疗法在癌症治疗中的临床进展
Pharmaceutics. 2021 Jul 2;13(7):1009. doi: 10.3390/pharmaceutics13071009.
9
The roles of tumor-derived exosomes in altered differentiation, maturation and function of dendritic cells.肿瘤来源的外泌体在树突状细胞分化、成熟和功能改变中的作用。
Mol Cancer. 2021 Jun 2;20(1):83. doi: 10.1186/s12943-021-01376-w.
10
Bioengineered siRNA-Based Nanoplatforms Targeting Molecular Signaling Pathways for the Treatment of Triple Negative Breast Cancer: Preclinical and Clinical Advancements.基于生物工程化小干扰RNA的纳米平台靶向分子信号通路治疗三阴性乳腺癌：临床前和临床进展
Pharmaceutics. 2020 Sep 29;12(10):929. doi: 10.3390/pharmaceutics12100929.

本文引用的文献

1
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer.外泌体有助于在胰腺癌中对致癌性KRAS进行治疗靶向。
Nature. 2017 Jun 22;546(7659):498-503. doi: 10.1038/nature22341. Epub 2017 Jun 7.
2
Cancer immunotherapy targeting the CD47/SIRPα axis.靶向CD47/SIRPα轴的癌症免疫疗法。
Eur J Cancer. 2017 May;76:100-109. doi: 10.1016/j.ejca.2017.02.013. Epub 2017 Mar 10.
3
Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis.外泌体-SIRPα，阻断 CD47 可增强癌细胞吞噬作用。
Biomaterials. 2017 Mar;121:121-129. doi: 10.1016/j.biomaterials.2017.01.004. Epub 2017 Jan 3.
4
Exosome-mediated Transfer of αvβ3 Integrin from Tumorigenic to Nontumorigenic Cells Promotes a Migratory Phenotype.外泌体介导αvβ3整合素从致瘤细胞向非致瘤细胞的转移促进迁移表型。
Mol Cancer Res. 2016 Nov;14(11):1136-1146. doi: 10.1158/1541-7786.MCR-16-0058. Epub 2016 Jul 20.
5
Introduction to Extracellular Vesicles: Biogenesis, RNA Cargo Selection, Content, Release, and Uptake.细胞外囊泡简介：生物发生、RNA 货物选择、内容物、释放和摄取
Cell Mol Neurobiol. 2016 Apr;36(3):301-12. doi: 10.1007/s10571-016-0366-z. Epub 2016 Apr 6.
6
Extracellular vesicles for drug delivery.细胞外囊泡用于药物递送。
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt A):148-156. doi: 10.1016/j.addr.2016.02.006. Epub 2016 Feb 27.
7
Apoptotic cell recognition receptors and scavenger receptors.凋亡细胞识别受体与清道夫受体
Immunol Rev. 2016 Jan;269(1):44-59. doi: 10.1111/imr.12376.
8
Extracellular vesicles shuffling intercellular messages: for good or for bad.细胞外囊泡传递细胞间信息：有利有弊。
Curr Opin Cell Biol. 2015 Aug;35:69-77. doi: 10.1016/j.ceb.2015.04.013. Epub 2015 May 19.
9
Routes and mechanisms of extracellular vesicle uptake.细胞外囊泡摄取的途径和机制。
J Extracell Vesicles. 2014 Aug 4;3. doi: 10.3402/jev.v3.24641. eCollection 2014.
10
Tumor-derived exosomes: A message delivery system for tumor progression.肿瘤衍生的外泌体：肿瘤进展的信息传递系统。
Commun Integr Biol. 2014 Jan 1;7(1):e28231. doi: 10.4161/cib.28231. Epub 2014 Feb 27.

Therapeutic targeting of oncogenic KRAS in pancreatic cancer by engineered exosomes.

作者信息

Whiteside Theresa L

机构信息

Departments of Pathology, Immunology and Otolaryngology, University of Pittsburgh School of Medicine, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.

出版信息

Transl Cancer Res. 2017 Dec;6(Suppl 9):S1406-S1408. doi: 10.21037/tcr.2017.10.32.

DOI:10.21037/tcr.2017.10.32
PMID:30956951
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6447077/
Abstract
摘要